NEW YORK, Sept. 17, 2020 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint” or the “Company”) (NASDAQ: CKPT), a clinical-stage immunotherapy […]
Proceeds intended to be used for debt repayment, maintenance capital expenditures, working capital and other general corporate purposesVANCOUVER, British Columbia, […]